Page last updated: 2024-09-03

1,3-dipropyl-8-phenylxanthine and Brain Inflammation

1,3-dipropyl-8-phenylxanthine has been researched along with Brain Inflammation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arca, K; Blech, B; Carter, J; Gritsch, D; Mbonde, AA; McKeon, A1
Baidez-Guerrero, AE; Hernandez-Clares, R; Martin-Fernandez, JJ; Martinez-Hernandez, E; Valero-Lopez, G1

Other Studies

2 other study(ies) available for 1,3-dipropyl-8-phenylxanthine and Brain Inflammation

ArticleYear
DPPX autoimmune encephalitis: A short report on two patients presenting with classic features of this rare but treatable disease.
    Multiple sclerosis and related disorders, 2021, Volume: 52

    Topics: Autoantibodies; Encephalitis; Hashimoto Disease; Humans; Xanthines

2021
[Progressive encephalitis due to anti-DPPX antibodies: a case with good response to treatment with rituximab].
    Revista de neurologia, 2017, Dec-01, Volume: 65, Issue:11

    Topics: Adult; Autoantibodies; Disease Progression; Encephalitis; Female; Humans; Immunologic Factors; Remission Induction; Rituximab; Xanthines

2017